NasdaqGM - Delayed Quote • USD
TransMedics Group, Inc. (TMDX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:47 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.05 | -0.04 | -0.23 | 0.32 |
| Low Estimate | -0.33 | -0.37 | -1.24 | -0.9 |
| High Estimate | 0.11 | 0.28 | 0.56 | 1.55 |
| Year Ago EPS | -0.08 | -0.03 | -0.77 | -0.23 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 83.78M | 88.42M | 366.99M | 489.97M |
| Low Estimate | 81.2M | 85.3M | 360M | 450.14M |
| High Estimate | 85.5M | 90.2M | 372.4M | 539.8M |
| Year Ago Sales | 41.55M | -- | 241.62M | 366.99M |
| Sales Growth (year/est) | 101.60% | -- | 51.90% | 33.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.25 | -0.13 | -0.16 | -0.03 |
| EPS Actual | -0.08 | -0.03 | -0.78 | 0.12 |
| Difference | 0.17 | 0.1 | -0.62 | 0.15 |
| Surprise % | 68.00% | 76.90% | -387.50% | 500.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.05 | -0.04 | -0.23 | 0.32 |
| 7 Days Ago | -0.05 | -0.04 | -0.23 | 0.32 |
| 30 Days Ago | -0.08 | -0.06 | -0.67 | 0.05 |
| 60 Days Ago | -0.23 | -0.13 | -1.26 | -0.27 |
| 90 Days Ago | -0.23 | -0.13 | -1.26 | -0.27 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TMDX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 37.50% | -- | -- | 5.40% |
| Next Qtr. | -33.30% | -- | -- | 10.90% |
| Current Year | 70.10% | -- | -- | 4.50% |
| Next Year | 239.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Piper Sandler: Overweight | 3/28/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/28/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 2/27/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 2/27/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2023 |
| Maintains | JP Morgan: Overweight to Overweight | 11/7/2023 |
Related Tickers
INMD InMode Ltd.
17.14
+0.71%
SWAV Shockwave Medical, Inc.
330.00
+0.31%
NARI Inari Medical, Inc.
38.42
+0.92%
DXCM DexCom, Inc.
124.34
-9.91%
ALGN Align Technology, Inc.
309.02
-0.48%
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
CLPT ClearPoint Neuro, Inc.
5.26
-0.94%
PODD Insulet Corporation
166.19
+1.23%
BSX Boston Scientific Corporation
73.17
-0.12%
OM Outset Medical, Inc.
2.4000
+0.84%